Mail

IRTC - iRhythm Technologies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

78.66

+0.21 (+0.27%)

At close: 4:00PM EDT

Stock chart is not supported by your current browser

Previous Close	78.45
Open	78.09
Bid	0.00 x 800
Ask	0.00 x 800
Day's Range	77.42 - 79.60
52 Week Range	58.99 - 98.37
Volume	303,114
Avg. Volume	490,961

Market Cap	1.942B
Beta (3Y Monthly)	1.68
PE Ratio (TTM)	N/A
EPS (TTM)	-1.87
Earnings Date	Jul 30, 2019 - Aug 5, 2019
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	98.29

Trade prices are not sourced from all markets

All

News

Press Releases

Simply Wall St.4 days ago
One Thing To Remember About The iRhythm Technologies, Inc. (NASDAQ:IRTC) Share Price
If you're interested in iRhythm Technologies, Inc. (NASDAQ:IRTC), then you might want to consider its beta (a measure...
GlobeNewswire12 days ago
iRhythm Technologies to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
SAN FRANCISCO, June 05, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.
GlobeNewswirelast month
iRhythm Technologies Announces Investor Update Webcast on May 9, 2019
SAN FRANCISCO, May 08, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health company focused on the advancement of cardiac care, announced today that it.
Motley Foollast month
iRhythm Technologies, Inc. Common Stock (IRTC) Q1 2019 Earnings Call Transcript
IRTC earnings call for the period ending March 31, 2019.
Zackslast month
IRHYTHM TECH (IRTC) Reports Q1 Loss, Tops Revenue Estimates
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of 34.00% and 8.25%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswirelast month
iRhythm Technologies Announces First Quarter 2019 Financial Results
SAN FRANCISCO, May 07, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.
ACCESSWIRElast month
iRhythm Technologies, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 7, 2019 / iRhythm Technologies, Inc. (NASDAQ: IRTC ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 7, 2019 at 4:30 PM ...
Insider Monkey2 months ago
Hedge Funds Have Never Been More Bullish On iRhythm Technologies, Inc. (IRTC)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. Since stock returns aren't usually symmetrically distributed and index […]
GlobeNewswire2 months ago
IRTC INVESTIGATION REMINDER: Hagens Berman Reminds iRhythm Technologies (IRTC) Investors of the Firm’s Ongoing Investigation, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm
Hagens Berman Sobol Shapiro LLP, with 9 offices in 8 cities around the country and 80 attorneys, reminds investors in iRhythm Technologies, Inc. (NASDAQ: IRTC) of the firm’s ongoing investigation of possible securities law violations.
Zacks2 months ago
Analysts Estimate IRHYTHM TECH (IRTC) to Report a Decline in Earnings: What to Look Out for
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GlobeNewswire2 months ago
iRhythm Technologies to Report First Quarter Financial Results on May 7, 2019
SAN FRANCISCO, April 23, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today.
Business Wire2 months ago
Glancy Prongay & Murray LLP Announces Investigation on Behalf of iRhythm Technologies, Inc. Investors (IRTC)
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) investors concerning the Company and its officers’ possible violations of federal securities laws. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. Between March 13 and March 27, 2019, a series of reports alleged that the Company’s revenue base relied on “an exceedingly generous, but increasingly fragile, reimbursement regime.” These reports also alleged that the Company engaged in deceptive accounting practices.
ACCESSWIRE2 months ago
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC)
NEW YORK, NY / ACCESSWIRE / April 10, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc.("iRhythm" or the "Company") ...
Business Wire2 months ago
Robbins Arroyo LLP Is Investigating the Officers and Directors of iRhythm Technologies, Inc. (IRTC) on Behalf of Shareholders
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of iRhythm Technologies, Inc. breached their fiduciary duties to shareholders by failing to maintain effective internal controls over financial reporting.
Business Wire2 months ago
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of iRhythm Technologies, Inc. Investors
Law Offices of Howard G. Smith announces an investigation on behalf of iRhythm Technologies, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.
Business Wire2 months ago
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Business Wire2 months ago
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
PR Newswire2 months ago
Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., iRhythm Technologies, Inc., Orion Group Holdings, Inc., Osmotica Pharmaceuticals plc, Quantenna Communications, Inc., WABCO Holdings, Inc. and Zafgen, Inc.
NEW YORK , April 2, 2019 /PRNewswire/ -- Amyris, Inc. (AMRS) Lifshitz & Miller announces investigation into possible securities laws violations in connection with Amyris' announcement that it was unable ...
ACCESSWIRE2 months ago
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 2, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
GlobeNewswire2 months ago
Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. (IRTC) on Behalf of Stockholders and Encourages IRTC Investors to Contact the Firm
NEW YORK, April 01, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against iRhythm Technologies, Inc. (NASDAQ: IRTC). Our investigation concerns.
GlobeNewswire3 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of iRhythm Technologies, Inc.
NEW YORK, April 01, 2019 -- Levi & Korsinsky announces it has commenced an investigation of iRhythm Technologies, Inc. (NASDAQGS: IRTC) concerning possible violations of.
ACCESSWIRE3 months ago
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC)
NEW YORK, NY / ACCESSWIRE / April 1, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc.("iRhythm" or the "Company") ...
GlobeNewswire3 months ago
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Analysts also questioned if the Company’s statements on the total addressable market for its products may have been misleading.